COPD: Page 3

Mixed results in phase 3 COPD drug trials
Itepekimab met primary endpoint in one study but not the other.
June 5, 2025
Pass Fail
Multidimensional approach could boost detection of COPD
New schema uses chest imaging, respiratory symptoms and spirometry.
June 5, 2025
Spirometry
FDA approves Nucala for use in adults with COPD
The decision was based on positive results from the phase 3 MATINEE and METREX trials.
May 28, 2025
Nucala Administration Options
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Companies partner on AI-powered tool for COPD patients
The technology aims to enhance detection and management for high-risk populations.
May 28, 2025
Ai Lungs
Novel therapeutic strategy targets senescent cells in COPD patients
The treatment could improve lung function, reduce inflammation and decrease lung tissue damage.
May 22, 2025
Epithelial Cells
Research raises red flag on persistent mucus plugs in COPD patients
Airway-clogging plugs have been linked to faster decline in lung function.
May 22, 2025
Getty Images 2184749337
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
New test could improve diagnoses of genetic COPD
Data suggest advanced molecular test can accurately identify alpha-1 antitrypsin deficiency.
May 14, 2025
Dna Extraction
Women non-smokers twice as likely to develop COPD than men
New research challenges the idea that heightened vulnerability to cigarette smoke is to blame.
May 14, 2025
Woman Non Smoker
Mepolizumab prevents exacerbations of certain types of COPD
Study finds it an effective treatment for COPD with an eosinophilic phenotype.
May 7, 2025
Scientist Inspecting Paperwork In Lab
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Novel rat model could advance COPD research
Recent research details the prototype’s ability to unravel the interactions between lung and heart pathology.
May 7, 2025
Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated cor pulmonale.
Stress may lead to worsened respiratory symptoms
Study examines how perceived stress impacts respiratory health and other factors associated with COPD.
May 1, 2025
Stress
Start-up looks to bring novel treatments for COPD, asthma
Researchers from the University of Arizona College of Medicine target the deeper causes of respiratory ailments.
May 1, 2025
(From left) The Aspiro Therapeutics team: James Lovgren, Stefano Guerra, MD, PhD, Josef Vagner, PhD, and Julie Ledford, PhD.
Previous Page
Page 3 of 17
Next Page
Most Popular
Brinsupri becomes first FDA-approved therapy for NCFB
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
CHEST publishes new guideline on NSCLC management
Zinc’s emerging role in pediatric asthma, allergic rhinitis
The best and worst states for lung health, COPD
Researchers create 3D-printed living lung tissue